Ability 0 7 0 7 O
to 8 10 8 10 O
become 11 17 11 17 O
pregnant 18 26 18 26 B-pregnancy

Active 0 6 27 33 O
hepatitis 7 16 34 43 B-chronic_disease
C 17 18 44 45 I-chronic_disease
virus 19 24 46 51 I-chronic_disease
( 25 26 52 53 I-chronic_disease
HCV 26 29 53 56 I-chronic_disease
) 29 30 56 57 I-chronic_disease
or 31 33 58 60 O
hepatitis 34 43 61 70 B-chronic_disease
B 44 45 71 72 I-chronic_disease
virus 46 51 73 78 I-chronic_disease
( 52 53 79 80 I-chronic_disease
HBV 53 56 80 83 I-chronic_disease
) 56 57 83 84 I-chronic_disease

Any 0 3 85 88 O
number 4 10 89 95 O
of 11 13 96 98 O
continuous 14 24 99 109 O
cycles 25 31 110 116 O
of 32 34 117 119 O
therapy 35 42 120 127 B-treatment
with 43 47 128 132 O
an 48 50 133 135 O
individual 51 61 136 146 O
hypomethylating 62 77 147 162 B-treatment
agent 78 83 163 168 I-treatment
count 84 89 169 174 O
as 90 92 175 177 O
one 93 96 178 181 O
induction 97 106 182 191 O
or 107 109 192 194 O
salvage 110 117 195 202 O
regimen 118 125 203 210 O

Blasts 0 6 211 217 B-clinical_variable
at 7 9 218 220 O
least 10 15 221 226 O
5 16 17 227 228 B-lower_bound
% 17 18 228 229 I-lower_bound
in 19 21 230 232 O
bone 22 26 233 237 O
marrow 27 33 238 244 O

Clinically 0 10 245 255 O
significant 11 22 256 267 O
cardiac 23 30 268 275 B-chronic_disease
disease 31 38 276 283 I-chronic_disease

Creatinine 0 10 284 294 B-clinical_variable
clearance 11 20 295 304 I-clinical_variable
> 21 22 305 306 O
50 23 25 307 309 B-lower_bound
mL 26 28 310 312 I-lower_bound
/ 28 29 312 313 I-lower_bound
min 29 32 313 316 I-lower_bound
( 33 34 317 318 O
measured 34 42 318 326 O
or 43 45 327 329 O
calculated 46 56 330 340 O
by 57 59 341 343 O
Cockcroft 60 69 344 353 O
- 69 70 353 354 O
Gault 70 75 354 359 O
method 76 82 360 366 O
) 82 83 366 367 O

Eastern 0 7 368 375 B-clinical_variable
Cooperative 8 19 376 387 I-clinical_variable
Oncology 20 28 388 396 I-clinical_variable
Group 29 34 397 402 I-clinical_variable
( 35 36 403 404 I-clinical_variable
ECOG 36 40 404 408 I-clinical_variable
) 40 41 408 409 I-clinical_variable
performance 42 53 410 421 I-clinical_variable
status 54 60 422 428 I-clinical_variable
of 61 63 429 431 O
0 64 65 432 433 B-lower_bound
or 66 68 434 436 O
1 69 70 437 438 B-upper_bound

Evidence 0 8 439 447 O
of 9 11 448 450 O
active 12 18 451 457 O
, 18 19 457 458 O
uncontrolled 20 32 459 471 O
, 32 33 471 472 O
viral 34 39 473 478 O
, 39 40 478 479 O
bacterial 41 50 480 489 B-chronic_disease
, 50 51 489 490 O
or 52 54 491 493 O
systemic 55 63 494 502 O
fungal 64 70 503 509 B-chronic_disease
infection 71 80 510 519 I-chronic_disease

First 0 5 520 525 O
untreated 6 15 526 535 O
relapse 16 23 536 543 O
after 24 29 544 549 O
a 30 31 550 551 O
first 32 37 552 557 O
CR 38 40 558 560 O
lasting 41 48 561 568 O
less 49 53 569 573 O
than 54 58 574 578 O
12 59 61 579 581 B-upper_bound
months 62 68 582 588 I-upper_bound
or 69 71 589 591 O
first 72 77 592 597 O
relapse 78 85 598 605 O
refractory 86 96 606 616 O
to 97 99 617 619 O
salvage 100 107 620 627 B-treatment
therapy 108 115 628 635 I-treatment
regardless 116 126 636 646 O
of 127 129 647 649 O
length 130 136 650 656 O
of 137 139 657 659 O
first 140 145 660 665 O
CR 146 148 666 668 O

History 0 7 669 676 O
of 8 10 677 679 O
, 10 11 679 680 O
or 12 14 681 683 O
known 15 20 684 689 O
, 20 21 689 690 O
central 22 29 691 698 B-chronic_disease
nervous 30 37 699 706 I-chronic_disease
system 38 44 707 713 I-chronic_disease
( 45 46 714 715 I-chronic_disease
CNS 46 49 715 718 I-chronic_disease
) 49 50 718 719 I-chronic_disease
disease 51 58 720 727 I-chronic_disease
involvement 59 70 728 739 O
, 70 71 739 740 O
or 72 74 741 743 O
prior 75 80 744 749 O
history 81 88 750 757 O
of 89 91 758 760 O
National 92 100 761 769 B-clinical_variable
Cancer 101 107 770 776 I-clinical_variable
Institute 108 117 777 786 I-clinical_variable
( 118 119 787 788 I-clinical_variable
NCI 119 122 788 791 I-clinical_variable
) 122 123 791 792 I-clinical_variable
Common 124 130 793 799 I-clinical_variable
Toxicity 131 139 800 808 I-clinical_variable
Criteria 140 148 809 817 I-clinical_variable
for 149 152 818 821 I-clinical_variable
Adverse 153 160 822 829 I-clinical_variable
Events 161 167 830 836 I-clinical_variable
( 168 169 837 838 I-clinical_variable
CTCAE 169 174 838 843 I-clinical_variable
) 174 175 843 844 I-clinical_variable
Grade 176 181 845 850 I-clinical_variable
≥ 182 183 851 852 O
3 184 185 853 854 B-lower_bound
drug 186 190 855 859 O
- 190 191 859 860 O
related 191 198 860 867 O
CNS 199 202 868 871 B-chronic_disease
toxicity 203 211 872 880 I-chronic_disease

Known 0 5 881 886 O
positive 6 14 887 895 O
test 15 19 896 900 O
result 20 26 901 907 O
for 27 30 908 911 O
human 31 36 912 917 B-chronic_disease
immunodeficiency 37 53 918 934 I-chronic_disease
virus 54 59 935 940 I-chronic_disease
( 60 61 941 942 I-chronic_disease
HIV 61 64 942 945 I-chronic_disease
) 64 65 945 946 I-chronic_disease
or 66 68 947 949 O
acquired 69 77 950 958 B-chronic_disease
immune 78 84 959 965 I-chronic_disease
deficiency 85 95 966 976 I-chronic_disease
syndrome 96 104 977 985 I-chronic_disease
( 105 106 986 987 I-chronic_disease
AIDS 106 110 987 991 I-chronic_disease
) 110 111 991 992 I-chronic_disease

Major 0 5 993 998 B-chronic_disease
trauma 6 12 999 1005 I-chronic_disease
or 13 15 1006 1008 O
major 16 21 1009 1014 B-treatment
surgery 22 29 1015 1022 I-treatment
within 30 36 1023 1029 O
28 37 39 1030 1032 B-upper_bound
days 40 44 1033 1037 I-upper_bound
prior 45 50 1038 1043 I-upper_bound
to 51 53 1044 1046 O
the 54 57 1047 1050 O
initiation 58 68 1051 1061 O
of 69 71 1062 1064 O
AMV564 72 78 1065 1071 B-treatment
treatment 79 88 1072 1081 I-treatment

Male 0 4 1082 1086 B-gender
patients 5 13 1087 1095 I-gender
with 14 18 1096 1100 O
partners 19 27 1101 1109 O
of 28 30 1110 1112 O
childbearing 31 43 1113 1125 O
potential 44 53 1126 1135 O

No 0 2 1136 1138 O
more 3 7 1139 1143 O
than 8 12 1144 1148 O
3 13 14 1149 1150 B-lower_bound
prior 15 20 1151 1156 I-lower_bound
induction 21 30 1157 1166 B-treatment
/ 30 31 1166 1167 O
salvage 31 38 1167 1174 B-treatment
regimens 39 47 1175 1183 I-treatment
to 48 50 1184 1186 O
treat 51 56 1187 1192 O
active 57 63 1193 1199 B-chronic_disease
disease 64 71 1200 1207 I-chronic_disease
, 71 72 1207 1208 O
and 73 76 1209 1212 O
no 77 79 1213 1215 O
more 80 84 1216 1220 O
than 85 89 1221 1225 O
1 90 91 1226 1227 B-lower_bound
prior 92 97 1228 1233 I-lower_bound
stem 98 102 1234 1238 B-treatment
cell 103 107 1239 1243 I-treatment
transplant 108 118 1244 1254 I-treatment

Patients 0 8 1255 1263 O
who 9 12 1264 1267 O
are 13 16 1268 1271 O
positive 17 25 1272 1280 O
for 26 29 1281 1284 O
hepatitis 30 39 1285 1294 B-chronic_disease
B 40 41 1295 1296 I-chronic_disease
core 42 46 1297 1301 O
antibody 47 55 1302 1310 O
, 55 56 1310 1311 O
hepatitis 57 66 1312 1321 O
B 67 68 1322 1323 O
surface 69 76 1324 1331 O
antigen 77 84 1332 1339 O
, 84 85 1339 1340 O
or 86 88 1341 1343 O
hepatitis 89 98 1344 1353 B-chronic_disease
C 99 100 1354 1355 I-chronic_disease
antibody 101 109 1356 1364 O
must 110 114 1365 1369 O
have 115 119 1370 1374 O
a 120 121 1375 1376 O
negative 122 130 1377 1385 O
polymerase 131 141 1386 1396 O
chain 142 147 1397 1402 O
reaction 148 156 1403 1411 O
( 157 158 1412 1413 O
PCR 158 161 1413 1416 O
) 161 162 1416 1417 O
result 163 169 1418 1424 O
before 170 176 1425 1431 O
enrollment 177 187 1432 1442 O

Peripheral 0 10 1443 1453 B-clinical_variable
white 11 16 1454 1459 I-clinical_variable
blood 17 22 1460 1465 I-clinical_variable
cell 23 27 1466 1470 I-clinical_variable
( 28 29 1471 1472 I-clinical_variable
WBC 29 32 1472 1475 I-clinical_variable
) 32 33 1475 1476 I-clinical_variable
count 34 39 1477 1482 I-clinical_variable
: 39 40 1482 1483 O
no 41 43 1484 1486 O
upper 44 49 1487 1492 O
limit 50 55 1493 1498 O
at 56 58 1499 1501 O
Screening 59 68 1502 1511 O
, 68 69 1511 1512 O
but 70 73 1513 1516 O
must 74 78 1517 1521 O
be 79 81 1522 1524 O
< 82 83 1525 1526 O
10 84 86 1527 1529 B-upper_bound
x 87 88 1530 1531 I-upper_bound
109 89 92 1532 1535 I-upper_bound
/ 92 93 1535 1536 I-upper_bound
L 93 94 1536 1537 I-upper_bound
on 95 97 1538 1540 O
Day 98 101 1541 1544 O
1 102 103 1545 1546 O
prior 104 109 1547 1552 O
to 110 112 1553 1555 O
treatment 113 122 1556 1565 O

Pregnant 0 8 1566 1574 B-pregnancy

Prior 0 5 1575 1580 B-treatment
allogeneic 6 16 1581 1591 I-treatment
transplant 17 27 1592 1602 I-treatment
< 28 29 1603 1604 O
3 30 31 1605 1606 B-upper_bound
months 32 38 1607 1613 I-upper_bound
prior 39 44 1614 1619 I-upper_bound
to 45 47 1620 1622 O
start 48 53 1623 1628 O
date 54 58 1629 1633 O
of 59 61 1634 1636 O
AMV564 62 68 1637 1643 O

Pulmonary 0 9 1644 1653 B-chronic_disease
, 9 10 1653 1654 O
renal 11 16 1655 1660 B-chronic_disease
, 16 17 1660 1661 O
hepatic 18 25 1662 1669 B-chronic_disease
, 25 26 1669 1670 O
gastrointestinal 27 43 1671 1687 B-chronic_disease
, 43 44 1687 1688 O
neurological 45 57 1689 1701 B-chronic_disease
or 58 60 1702 1704 O
psychiatric 61 72 1705 1716 B-chronic_disease
disease 73 80 1717 1724 I-chronic_disease
that 81 85 1725 1729 O
would 86 91 1730 1735 O
limit 92 97 1736 1741 O
compliance 98 108 1742 1752 O
with 109 113 1753 1757 O
study 114 119 1758 1763 O
requirements 120 132 1764 1776 O

Relapsed 0 8 1777 1785 B-chronic_disease
or 9 11 1786 1788 O
refractory 12 22 1789 1799 B-cancer
disease 23 30 1800 1807 I-cancer

Second 0 6 1808 1814 O
or 7 9 1815 1817 O
later 10 15 1818 1823 O
relapse 16 23 1824 1831 O
. 23 24 1831 1832 O
Relapse 25 32 1833 1840 O
is 33 35 1841 1843 O
defined 36 43 1844 1851 O
as 44 46 1852 1854 O
the 47 50 1855 1858 O
reappearance 51 63 1859 1871 O
of 64 66 1872 1874 O
leukemic 67 75 1875 1883 O
blasts 76 82 1884 1890 O
in 83 85 1891 1893 O
the 86 89 1894 1897 O
peripheral 90 100 1898 1908 O
blood 101 106 1909 1914 O
or 107 109 1915 1917 O
≥ 110 111 1918 1919 O
5 112 113 1920 1921 B-lower_bound
% 113 114 1921 1922 I-lower_bound
leukemic 115 123 1923 1931 O
blasts 124 130 1932 1938 O
in 131 133 1939 1941 O
the 134 137 1942 1945 O
bone 138 142 1946 1950 O
marrow 143 149 1951 1957 O
after 150 155 1958 1963 O
prior 156 161 1964 1969 O
achievement 162 173 1970 1981 O
of 174 176 1982 1984 O
a 177 178 1985 1986 O
CR 179 181 1987 1989 O
or 182 184 1990 1992 O
CRi 185 188 1993 1996 O

Second 0 6 1997 2003 B-cancer
primary 7 14 2004 2011 I-cancer
malignancy 15 25 2012 2022 I-cancer
that 26 30 2023 2027 O
has 31 34 2028 2031 O
not 35 38 2032 2035 O
been 39 43 2036 2040 O
in 44 46 2041 2043 O
remission 47 56 2044 2053 O
for 57 60 2054 2057 O
greater 61 68 2058 2065 O
than 69 73 2066 2070 O
3 74 75 2071 2072 B-lower_bound
years 76 81 2073 2078 I-lower_bound

Total 0 5 2079 2084 B-clinical_variable
bilirubin 6 15 2085 2094 I-clinical_variable
≤ 16 17 2095 2096 O
1.5x 18 22 2097 2101 B-upper_bound
the 23 26 2102 2105 I-upper_bound
ULN 27 30 2106 2109 I-upper_bound

Treatment 0 9 2110 2119 O
with 10 14 2120 2124 O
anti 15 19 2125 2129 B-treatment
- 19 20 2129 2130 I-treatment
thymocyte 20 29 2130 2139 I-treatment
globulin 30 38 2140 2148 I-treatment
( 39 40 2149 2150 I-treatment
ATG 40 43 2150 2153 I-treatment
) 43 44 2153 2154 I-treatment
within 45 51 2155 2161 O
14 52 54 2162 2164 B-upper_bound
days 55 59 2165 2169 I-upper_bound
prior 60 65 2170 2175 I-upper_bound
to 66 68 2176 2178 O
start 69 74 2179 2184 O
date 75 79 2185 2189 O

Willing 0 7 2190 2197 O
to 8 10 2198 2200 O
complete 11 19 2201 2209 O
all 20 23 2210 2213 O
scheduled 24 33 2214 2223 O
visits 34 40 2224 2230 O
and 41 44 2231 2234 O
assessments 45 56 2235 2246 O
at 57 59 2247 2249 O
the 60 63 2250 2253 O
institution 64 75 2254 2265 O
administering 76 89 2266 2279 O
therapy 90 97 2280 2287 B-treatment

female 0 6 2288 2294 B-gender
patients 7 15 2295 2303 I-gender
who 16 19 2304 2307 O
have 20 24 2308 2312 O
a 25 26 2313 2314 O
negative 27 35 2315 2323 B-pregnancy
serum 36 41 2324 2329 I-pregnancy
or 42 44 2330 2332 I-pregnancy
urine 45 50 2333 2338 I-pregnancy
pregnancy 51 60 2339 2348 I-pregnancy
test 61 65 2349 2353 O
before 66 72 2354 2360 O
enrollment 73 83 2361 2371 O
and 84 87 2372 2375 O
agree 88 93 2376 2381 B-contraception_consent
to 94 96 2382 2384 I-contraception_consent
use 97 100 2385 2388 I-contraception_consent
two 101 104 2389 2392 I-contraception_consent
highly 105 111 2393 2399 I-contraception_consent
effective 112 121 2400 2409 I-contraception_consent
forms 122 127 2410 2415 I-contraception_consent
of 128 130 2416 2418 I-contraception_consent
contraception 131 144 2419 2432 I-contraception_consent
( 145 146 2433 2434 O
oral 146 150 2434 2438 O
, 150 151 2438 2439 O
injected 152 160 2440 2448 O
or 161 163 2449 2451 O
implanted 164 173 2452 2461 O
hormonal 174 182 2462 2470 O
contraception 183 196 2471 2484 O
and 197 200 2485 2488 O
condom 201 207 2489 2495 O
; 207 208 2495 2496 O
intrauterine 209 221 2497 2509 O
device 222 228 2510 2516 O
and 229 232 2517 2520 O
condom 233 239 2521 2527 O
; 239 240 2527 2528 O
diaphragm 241 250 2529 2538 O
with 251 255 2539 2543 O
spermicidal 256 267 2544 2555 O
gel 268 271 2556 2559 O
and 272 275 2560 2563 O
condom 276 282 2564 2570 O
) 282 283 2570 2571 O
during 284 290 2572 2578 O
the 291 294 2579 2582 O
trial 295 300 2583 2588 O
and 301 304 2589 2592 O
for 305 308 2593 2596 O
90 309 311 2597 2599 O
days 312 316 2600 2604 O
afterward 317 326 2605 2614 O
( 327 328 2615 2616 O
90 328 330 2616 2618 O
days 331 335 2619 2623 O
after 336 341 2624 2629 O
the 342 345 2630 2633 O
end 346 349 2634 2637 O
of 350 352 2638 2640 O
AMV564 353 359 2641 2647 O
treatment 360 369 2648 2657 O
) 369 370 2657 2658 O

non 0 3 2659 2662 B-cancer
- 3 4 2662 2663 I-cancer
melanoma 4 12 2663 2671 I-cancer
skin 13 17 2672 2676 I-cancer
cancer 18 24 2677 2683 I-cancer
; 24 25 2683 2684 O
cervical 26 34 2685 2693 B-cancer
carcinoma 35 44 2694 2703 I-cancer
in 45 47 2704 2706 I-cancer
situ 48 52 2707 2711 I-cancer
on 53 55 2712 2714 O
biopsy 56 62 2715 2721 O
or 63 65 2722 2724 O
squamous 66 74 2725 2733 B-cancer
intraepithelial 75 90 2734 2749 I-cancer
lesion 91 97 2750 2756 I-cancer
on 98 100 2757 2759 O
Papanicolaou 101 113 2760 2772 B-treatment
( 114 115 2773 2774 I-treatment
PAP 115 118 2774 2777 I-treatment
) 118 119 2777 2778 I-treatment
smear 120 125 2779 2784 I-treatment
; 125 126 2784 2785 O
localized 127 136 2786 2795 B-cancer
prostate 137 145 2796 2804 I-cancer
cancer 146 152 2805 2811 I-cancer
( 153 154 2812 2813 O
Gleason 154 161 2813 2820 B-clinical_variable
score 162 167 2821 2826 I-clinical_variable
< 168 169 2827 2828 O
6 170 171 2829 2830 B-upper_bound
) 171 172 2830 2831 O
; 172 173 2831 2832 O
or 174 176 2833 2835 O
resected 177 185 2836 2844 O
melanoma 186 194 2845 2853 B-cancer
in 195 197 2854 2856 I-cancer
situ 198 202 2857 2861 I-cancer

participant 0 11 2862 2873 O
or 12 14 2874 2876 O
plans 15 20 2877 2882 O
to 21 23 2883 2885 O
participate 24 35 2886 2897 O
in 36 38 2898 2900 O
another 39 46 2901 2908 O
interventional 47 61 2909 2923 B-treatment
clinical 62 70 2924 2932 I-treatment
study 71 76 2933 2938 I-treatment

patients 0 8 2939 2947 O
with 9 13 2948 2952 O
excessive 14 23 2953 2962 O
blasts 24 30 2963 2969 O
may 31 34 2970 2973 O
be 35 37 2974 2976 O
treated 38 45 2977 2984 O
with 46 50 2985 2989 O
hydroxyurea 51 62 2990 3001 B-treatment
to 63 65 3002 3004 O
bring 66 71 3005 3010 O
counts 72 78 3011 3017 O
down 79 83 3018 3022 O

≥ 0 1 3023 3024 O
18 2 4 3025 3027 B-lower_bound
years 5 10 3028 3033 I-lower_bound
of 11 13 3034 3036 O
age 14 17 3037 3040 B-age
at 18 20 3041 3043 O
the 21 24 3044 3047 O
time 25 29 3048 3052 O
of 30 32 3053 3055 O
signing 33 40 3056 3063 O
informed 41 49 3064 3072 O
consent 50 57 3073 3080 O

